Vygon signs exclusive agreement with Carmat to develop and manufacture vascular graft compatible with Aeson artificial heart
June, 21th 2023
Collaboration between two prominent medtech companies will see Vygon create vascular graft to connect Carmat’s artificial heart to patients’ arteries